{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:14:20Z","timestamp":1784085260758,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Health, Labor and Welfare"},{"name":"National Institute of Biomedical Innovation of Japan"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Proteomics"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.jprot.2011.09.026","type":"journal-article","created":{"date-parts":[[2011,10,7]],"date-time":"2011-10-07T22:18:39Z","timestamp":1318025919000},"page":"833-844","source":"Crossref","is-referenced-by-count":16,"title":["Proteomic study of malignant pleural mesothelioma by laser microdissection and two-dimensional difference gel electrophoresis identified cathepsin D as a novel candidate for a differential diagnosis biomarker"],"prefix":"10.1016","volume":"75","author":[{"given":"Mutsumi","family":"Hosako","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taika","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Tsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naobumi","family":"Tochigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisao","family":"Asamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Tomonaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jprot.2011.09.026_bb0165","series-title":"Tumours of the lung, pleurs, thymus and heart","year":"2003"},{"key":"10.1016\/j.jprot.2011.09.026_bb0010","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3816\/CLC.2004.n.008","article-title":"Integration of multimodality approaches in the management of malignant pleural mesothelioma","volume":"5","author":"Martino","year":"2004","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jprot.2011.09.026_bb0015","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jprot.2011.09.026_bb0020","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jprot.2011.09.026_bb0025","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000109618","article-title":"Gene copy number analysis in malignant pleural mesothelioma using oligonucleotide array CGH","volume":"119","author":"Lindholm","year":"2007","journal-title":"Cytogenet Genome Res"},{"key":"10.1016\/j.jprot.2011.09.026_bb0170","first-page":"450","article-title":"Comparative genomic hybridization and loss of heterozygosity analyses identify a common region of deletion at 15q11.1-15 in human malignant mesothelioma","volume":"59","author":"Balsara","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.jprot.2011.09.026_bb0035","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/bjc.1997.91","article-title":"Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q and 22q detected by comparative genomic hybridization in malignant mesothelioma","volume":"75","author":"Bjorkqvist","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jprot.2011.09.026_bb0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0169-5002(02)00178-2","article-title":"Inactivation of p16INK4a expression in malignant mesothelioma by methylation","volume":"38","author":"Wong","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jprot.2011.09.026_bb0045","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/jnci\/92.8.636","article-title":"Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells","volume":"92","author":"Yang","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jprot.2011.09.026_bb0050","first-page":"1009","article-title":"Mutational analysis of the nf2 tumour suppressor gene in three subtypes of primary human malignant mesotheliomas","volume":"22","author":"Schipper","year":"2003","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jprot.2011.09.026_bb0055","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1158\/0008-5472.CAN-09-1595","article-title":"Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma","volume":"69","author":"Goto","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jprot.2011.09.026_bb0175","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1073\/pnas.0712399105","article-title":"Transcriptome sequencing of malignant pleural mesothelioma tumors","volume":"105","author":"Sugarbaker","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jprot.2011.09.026_bb0065","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1158\/0008-5472.CAN-08-1363","article-title":"Identification of MCAM\/CD146 as the target antigen of a human monoclonal antibody that recognizes both epithelioid and sarcomatoid types of mesothelioma","volume":"69","author":"Bidlingmaier","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jprot.2011.09.026_bb0070","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/153303460900800502","article-title":"Protein profiling of pleural effusions to identify malignant pleural mesothelioma using SELDI-TOF MS","volume":"8","author":"Hegmans","year":"2009","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.jprot.2011.09.026_bb0075","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0002-9440(10)63739-X","article-title":"Proteomic analysis of exosomes secreted by human mesothelioma cells","volume":"164","author":"Hegmans","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jprot.2011.09.026_bb0080","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/1947601910375273","article-title":"A phosphotyrosine proteomic screen identifies multiple tyrosine kinase signaling pathways aberrantly activated in malignant mesothelioma","volume":"1","author":"Menges","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.jprot.2011.09.026_bb0085","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1002\/pmic.200800284","article-title":"Proteomic differential display analysis identified upregulated astrocytic phosphoprotein PEA-15 in human malignant pleural mesothelioma cell lines","volume":"9","author":"Kuramitsu","year":"2009","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2011.09.026_bb0180","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1038\/onc.2010.555","article-title":"AXL regulates mesothelioma proliferation and invasiveness","volume":"30","author":"Ou","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.jprot.2011.09.026_bb0095","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1593\/neo.101156","article-title":"Targeted inhibition of multiple receptor tyrosine kinases in mesothelioma","volume":"13","author":"Ou","year":"2011","journal-title":"Neoplasia"},{"key":"10.1016\/j.jprot.2011.09.026_bb0100","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/pmic.200300531","article-title":"Application of sensitive fluorescent dyes in linkage of laser microdissection and two-dimensional gel electrophoresis as a cancer proteomic study tool","volume":"3","author":"Kondo","year":"2003","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2011.09.026_bb0105","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1038\/nprot.2006.421","article-title":"Application of highly sensitive fluorescent dyes (CyDye DIGE Fluor saturation dyes) to laser microdissection and two-dimensional difference gel electrophoresis (2D-DIGE) for cancer proteomics","volume":"1","author":"Kondo","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jprot.2011.09.026_bb0185","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.1002\/pmic.200600488","article-title":"Protein clusters associated with carcinogenesis, histological differentiation and nodal metastasis in esophageal cancer","volume":"6","author":"Hatakeyama","year":"2006","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2011.09.026_bb0120","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.22552","article-title":"Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma","volume":"48","author":"Orimo","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jprot.2011.09.026_bb0125","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/ijc.24194","article-title":"Transglutaminase 3 as a prognostic biomarker in esophageal cancer revealed by proteomics","volume":"124","author":"Uemura","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jprot.2011.09.026_bb0130","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1002\/pmic.200401286","article-title":"Protein expression pattern distinguishes different lymphoid neoplasms","volume":"5","author":"Fujii","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2011.09.026_bb0135","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1002\/pmic.200600196","article-title":"Proteomic signatures corresponding to histological classification and grading of soft-tissue sarcomas","volume":"6","author":"Suehara","year":"2006","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2011.09.026_bb0140","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1200\/JCO.2001.19.6.1734","article-title":"Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results","volume":"19","author":"Breathnach","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jprot.2011.09.026_bb0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1586\/epr.09.87","article-title":"Cancer proteome-expression database: Genome Medicine Database of Japan Proteomics","volume":"7","author":"Kondo","year":"2010","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.jprot.2011.09.026_bb0150","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1096-9098(199705)65:1<10::AID-JSO3>3.0.CO;2-R","article-title":"Influence of cathepsin D expression in lung adenocarcinoma on prognosis: possible importance of its expression in tumor cells and stromal cells, and its intracellular polarization in tumor cells","volume":"65","author":"Higashiyama","year":"1997","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jprot.2011.09.026_bb0190","first-page":"1237","article-title":"2-DE analysis of breast cancer cell lines 1833 and 4175 with distinct metastatic organ-specific potentials: comparison with parental cell line MDA-MB-231","volume":"19","author":"Selicharova","year":"2008","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jprot.2011.09.026_bb0160","first-page":"1223","article-title":"Ribozyme-targeting procathepsin D and its effect on invasion and growth of breast cancer cells: an implication in breast cancer therapy","volume":"30","author":"Vashishta","year":"2007","journal-title":"Int J Oncol"}],"container-title":["Journal of Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874391911004805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874391911004805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T16:56:23Z","timestamp":1543510583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874391911004805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1874391911004805"],"URL":"https:\/\/doi.org\/10.1016\/j.jprot.2011.09.026","relation":{},"ISSN":["1874-3919"],"issn-type":[{"value":"1874-3919","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}